1. Panic attack disorder 2. Panic attack disorder combined with comorbidity psychiatric conditions Mental and Behavioural Disorders Panic attack disorder
Conditions
Interventions
All patients undergo administration of a xenon-oxygen mixture via a face mask. Each patient in the study undergoes between 6 and 7 treatments with xenon-oxygen mixture. The first three sessions are ca
Sponsors
Nobilis Therapeutics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of panic disorder (F41.0) according to ICD-10 2. Age 18-75 3. Willing to sign informed consent
Exclusion criteria
Exclusion criteria: 1. Known reactions to xenon therapy 2. Organ failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of panic attacks are assessed through self-reporting throughout the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Anxiety is measured by the “anxiety” subset of the Hospital Anxiety and Depression Scale (HADS_T) at baseline, 30 and 180 days 2. Severity of disease is assessed by Clinical Global Impression Scale Improvement Subscale (CGI-I) at baseline, 30 and 180 days 3. Symptom changes are quantified by the Zung Self-Rating Anxiety Scale (SAS) at baseline, 30 and 180 days 4. Depression is assessed by the “Depression” subset of the Hospital Anxiety and Depression Scale (HADS_T) at baseline, 30 and 180 days | — |
Countries
Russian Federation
Outcome results
None listed